Literature DB >> 3056242

Ceftazidime concentration in gallbladder tissue and excretion in bile.

K Shiramatsu1, K Hirata, T Yamada, H Kimura, T Someya, T Usuki, G Karasawa, H Hayasaka.   

Abstract

Ceftazidime was given to 16 patients with cholelithiasis, and its concentrations in bile and the gallbladder wall were studied. The results suggest that ceftazidime is effective against biliary tract infection.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3056242      PMCID： PMC175925          DOI： 10.1128/AAC.32.10.1588

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  2 in total

1.  Ceftazidime--a new extended-spectrum cephalosporin.

Authors:  D I Gozzard; A M Geddes; I D Farrell; S J Eykyn; I Phillips; R Wise; R M Brown
Journal:  Lancet       Date:  1982-05-22       Impact factor: 79.321

2.  Comparison of in vitro activity of GR 20263, a novel cephalosporin derivative, with activities of other beta-lactam compounds.

Authors:  R Wise; J M Andrews; K A Bedford
Journal:  Antimicrob Agents Chemother       Date:  1980-05       Impact factor: 5.191
  2 in total
  2 in total

Review 1.  Ceftazidime. An update of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  C P Rains; H M Bryson; D H Peters
Journal:  Drugs       Date:  1995-04       Impact factor: 9.546

Review 2.  Role of cephalosporins in the era of Clostridium difficile infection.

Authors:  Mark H Wilcox; James D Chalmers; Carl E Nord; Jane Freeman; Emilio Bouza
Journal:  J Antimicrob Chemother       Date:  2016-09-22       Impact factor: 5.790
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.